selected publications
- Pulmonary embolism versus pulmonary vasculitis in Hughes-Stovin syndrome: Characteristic computed tomography pulmonary angiographic findings and diagnostic and therapeutic implications. HSS International Study Group. Thrombosis research. 2024 Academic Article GET IT
-
Rethinking antiphospholipid syndrome to guide future management and research.
Nature reviews. Rheumatology.
2024
Review
GET IT
Times cited: 1 - The clinical relevance of different antiphospholipid antibody profiles in pediatric rheumatology patients. Pediatric rheumatology online journal. 2024 Academic Article GET IT
- Cardiac involvement in the catastrophic antiphospholipid syndrome (CAPS): Lessons from the "CAPS registry". Seminars in arthritis and rheumatism. 2024 Academic Article GET IT
- Reply. Arthritis & rheumatology (Hoboken, N.J.). 2024 Letter GET IT
-
Persistent Moderate-to-High Levels of Isolated Anticardiolipin Antibody IgA or Anti-β2-Glycoprotein-I IgA Isotypes: Do They Have Any Clinical Relevance?.
Turkish journal of haematology : official journal of Turkish Society of Haematology.
2024
Letter
GET IT
Times cited: 1 -
Response to: Correspondence on '2023 ACR/EULAR antiphospholipid syndrome classification criteria' by Miro-Mur et al.
Annals of the rheumatic diseases.
2024
Academic Article
GET IT
Times cited: 1 - Response to: Correspondence on '2023 ACR/EULAR antiphospholipid syndrome classification criteria' by Tang et al. Annals of the rheumatic diseases. 2024 Academic Article GET IT
-
Response to: Correspondence on 'ACR/EULAR antiphospholipid syndrome classification criteria' by Damoiseaux and van Beers.
Annals of the rheumatic diseases.
2024
Academic Article
GET IT
Times cited: 1 - Antiphospholipid Syndrome: To Classify or Not to Classify?. Turkish journal of haematology : official journal of Turkish Society of Haematology. 2024 Academic Article GET IT
- Mycophenolate mofetil withdrawal in patients with systemic lupus erythematosus: a multicentre, open-label, randomised controlled trial. The Lancet. Rheumatology. 2024 Academic Article GET IT
- Reply. Arthritis & rheumatology (Hoboken, N.J.). 2024 Letter GET IT
- Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository ("Registry"). Seminars in arthritis and rheumatism. 2023 Academic Article GET IT
- A new approach to antiphospholipid antibody syndrome. Research and practice in thrombosis and haemostasis. 2023 Academic Article GET IT
-
Pulmonary involvement in catastrophic antiphospholipid syndrome: A descriptive analysis from the "CAPS Registry".
Seminars in arthritis and rheumatism.
2023
Academic Article
GET IT
Times cited: 1 -
2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria.
Arthritis & rheumatology (Hoboken, N.J.).
2023
Academic Article
GET IT
Times cited: 1 - 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Annals of the rheumatic diseases. 2023 Academic Article GET IT
- Controversies in the Management of Antiphospholipid Syndrome. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases. 2023 Academic Article GET IT
- Damage measured by damage index for antiphosphlipid syndrome in antiphospholipid antibody-positive patients included in APS ACTION Registry. Rheumatology (Oxford, England). 2023 Academic Article GET IT
-
The ABCs of antiphospholipid syndrome.
Archives of rheumatology.
2023
Review
GET IT
Times cited: 6 -
Anti-Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody-Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository.
Arthritis & rheumatology (Hoboken, N.J.).
2023
Academic Article
GET IT
Times cited: 5 - Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study. Laboratory investigation; a journal of technical methods and pathology. 2023 Academic Article GET IT
-
Fluctuation of Anti-Domain 1 and Anti-β2 -Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies.
Arthritis & rheumatology (Hoboken, N.J.).
2023
Academic Article
GET IT
Times cited: 1 -
Incidence of Antiphospholipid Syndrome: Is Estimation Currently Possible?.
European journal of rheumatology.
2023
Academic Article
GET IT
Times cited: 90 -
COVID-19 and antiphospholipid antibodies.
Best practice & research. Clinical haematology.
2022
Review
GET IT
Times cited: 17 - Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry"). Lupus. 2022 Academic Article GET IT
-
Risk of livedo with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
Lupus.
2022
Review
GET IT
Times cited: 1 - Increased risk of acute and chronic microvascular renal lesions associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis. Autoimmunity reviews. 2022 Review GET IT
- Mammalian Target of Rapamycin Pathway Assessment in Antiphospholipid Antibody Positive Patients with Livedo. The Journal of rheumatology. 2022 Academic Article GET IT
- Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ('Registry'). Lupus science & medicine. 2022 Academic Article GET IT
- Treatment advances in antiphospholipid syndrome: 2022 update. Current opinion in pharmacology. 2022 Review GET IT
-
Defibrotide Inhibits Antiphospholipid Antibody-Mediated Neutrophil Extracellular Trap Formation and Venous Thrombosis.
Arthritis & rheumatology (Hoboken, N.J.).
2022
Academic Article
GET IT
Times cited: 25 -
Eculizumab use in catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis from the "CAPS Registry".
Autoimmunity reviews.
2022
Review
GET IT
Times cited: 2 - COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION). Lupus. 2021 Academic Article GET IT
- Clinical and laboratory characteristics of Brazilian versus non-Brazilian primary antiphospholipid syndrome patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository. Advances in rheumatology (London, England). 2021 Academic Article GET IT
-
Pulmonary vasculitis in Hughes-Stovin syndrome (HSS): a reference atlas and computed tomography pulmonary angiography guide-a report by the HSS International Study Group.
Clinical rheumatology.
2021
Academic Article
GET IT
Times cited: 16 -
Expert Perspective: Management of Microvascular and Catastrophic Antiphospholipid Syndrome.
Arthritis & rheumatology (Hoboken, N.J.).
2021
Academic Article
GET IT
Times cited: 2 -
Antiphospholipid antibodies and the risk of autoimmune hemolytic anemia in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
Autoimmunity reviews.
2021
Review
GET IT
Times cited: 4 -
16th International congress on antiphospholipid antibodies task force report on clinical manifestations of antiphospholipid syndrome.
Lupus.
2021
Academic Article
GET IT
Times cited: 2 -
Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): 10-Year Update.
Current rheumatology reports.
2021
Review
GET IT
Times cited: 14 -
A critical analysis of 57 cases of Hughes-Stovin syndrome (HSS). A report by the HSS International Study Group (HSSISG).
International journal of cardiology.
2021
Editorial Article
GET IT
Times cited: 4 -
Reality Check on Antiphospholipid Antibodies in COVID-19-Associated Coagulopathy.
Arthritis & rheumatology (Hoboken, N.J.).
2020
Article
GET IT
Times cited: 11 -
A Covid-19 Patient with Complement-Mediated Coagulopathy and Severe Thrombosis.
2020
GET IT
Times cited: 8 -
Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: Update of the guidelines for lupus anticoagulant detection and interpretation.
Journal of thrombosis and haemostasis : JTH.
2020
Academic Article
GET IT
Times cited: 22 - Characteristics of Antiphospholipid Antibody Positive Patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking. Arthritis care & research. 2020 Academic Article GET IT
-
Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications.
Nature reviews. Rheumatology.
2020
Information Resource
GET IT
Times cited: 177 -
Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry.
Lupus.
2020
Academic Article
GET IT
Times cited: 34 - Recurrent Complement-Mediated Thrombotic Microangiopathy in a Patient with Systemic Lupus Erythematosus: A Clinical Pathology Conference Held by the Division of Rheumatology at Hospital for Special Surgery. HSS journal : the musculoskeletal journal of Hospital for Special Surgery. 2020 Academic Article GET IT
- Recurrent Complement-Mediated Thrombotic Microangiopathy in a Patient with Systemic Lupus Erythematosus: A Clinical Pathology Conference Held by the Division of Rheumatology at Hospital for Special Surgery. HSS Journal. 2020 Article GET IT
-
Antiphospholipid antibodies and the risk of thrombocytopenia in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
Autoimmunity reviews.
2019
Information Resource
GET IT
Times cited: 16 -
Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository.
Journal of thrombosis and haemostasis : JTH.
2019
Academic Article
GET IT
Times cited: 5 -
Clinical Insights into Diffuse Alveolar Hemorrhage in Antiphospholipid Syndrome.
Current rheumatology reports.
2019
Information Resource
GET IT
Times cited: 22 - Impact of antiphospholipid syndrome iBook on medical students' improvement of knowledge: An international randomized controlled study. European journal of rheumatology. 2019 Academic Article GET IT
-
Pathogenic Autoreactive T and B Cells Cross-React with Mimotopes Expressed by a Common Human Gut Commensal to Trigger Autoimmunity.
Cell host & microbe.
2019
Academic Article
GET IT
Times cited: 113 - The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort. Seminars in arthritis and rheumatism. 2019 Academic Article GET IT
-
The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis.
Thrombosis research.
2019
Academic Article
GET IT
Times cited: 8 -
The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository.
Arthritis care & research.
2019
Academic Article
GET IT
Times cited: 38 -
Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study.
BJOG : an international journal of obstetrics and gynaecology.
2018
Academic Article
GET IT
Times cited: 34 -
Diagnosis and Management of the Antiphospholipid Syndrome.
The New England journal of medicine.
2018
Letter
GET IT
Times cited: 25 -
Primary Thrombosis Prophylaxis in Persistently Antiphospholipid Antibody-Positive Individuals: Where Do We Stand in 2018?.
Current rheumatology reports.
2018
Information Resource
GET IT
Times cited: 7 -
Longitudinal evaluation of diffusion tensor imaging and cognition in systemic lupus erythematosus.
Lupus.
2018
Academic Article
GET IT
Times cited: 12 -
The effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients.
Rheumatology (Oxford, England).
2018
Academic Article
GET IT
Times cited: 35 -
McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome.
Journal of thrombosis and haemostasis : JTH.
2018
Academic Article
GET IT
Times cited: 46 -
Diagnosis and Management of the Antiphospholipid Syndrome.
The New England journal of medicine.
2018
Information Resource
GET IT
Times cited: 210 -
Adult-Onset Still's Disease and Macrophage-Activating Syndrome Progressing to Lymphoma: A Clinical Pathology Conference Held by the Division of Rheumatology at Hospital for Special Surgery.
HSS journal : the musculoskeletal journal of Hospital for Special Surgery.
2018
Academic Article
GET IT
Times cited: 4 - Infodemiology of antiphospholipid syndrome: Merging informatics and epidemiology. European journal of rheumatology. 2018 Academic Article GET IT
-
Variants in chondroitin sulfate metabolism genes in thrombotic storm.
Thrombosis research.
2017
Academic Article
GET IT
Times cited: 1 -
Recurrent thrombosis in patients with antiphospholipid antibodies and arterial thrombosis on antithrombotic therapy.
Blood advances.
2017
Academic Article
GET IT
Times cited: 44 -
Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune disease.
Lupus.
2017
Academic Article
GET IT
Times cited: 30 -
Comment on: "The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome".
Thrombosis research.
2017
Article
GET IT
Times cited: 4 -
Cardiovascular Disease Prevention Counseling Program for Systemic Lupus Erythematosus Patients.
Arthritis care & research.
2017
Academic Article
GET IT
Times cited: 9 -
Immunoglobulin G4-related Aortitis: A Clinical Pathology Conference Held by the Division of Rheumatology at the Hospital for Special Surgery.
HSS journal : the musculoskeletal journal of Hospital for Special Surgery.
2017
Academic Article
GET IT
Times cited: 2 -
Antiphospholipid antibodies can identify lupus patients at risk of pulmonary hypertension: A systematic review and meta-analysis.
Autoimmunity reviews.
2017
Information Resource
GET IT
Times cited: 26 -
Catastrophic Antiphospholipid Syndrome: Candidate Therapies for a Potentially Lethal Disease.
Annual review of medicine.
2017
Information Resource
GET IT
Times cited: 14 -
Belimumab in primary antiphospholipid syndrome.
Lupus.
2016
Article
GET IT
Times cited: 21 -
Functional Magnetic Resonance Imaging of Working Memory and Executive Dysfunction in Systemic Lupus Erythematosus and Antiphospholipid Antibody-Positive Patients.
Arthritis care & research.
2016
Academic Article
GET IT
Times cited: 14 - Miscellaneous inflammatory musculoskeletal conditions: Always a diagnostic and therapeutic challenge. Best practice & research. Clinical rheumatology. 2016 Editorial Article GET IT
-
AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION): 5-Year Update.
Current rheumatology reports.
2016
Information Resource
GET IT
Times cited: 9 -
Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry.
Autoimmunity reviews.
2016
Information Resource
GET IT
Times cited: 114 -
Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assay.
Clinical and molecular allergy : CMA.
2016
Information Resource
GET IT
Times cited: 35 - Proceedings of the 2016 Childhood Arthritis and Rheumatology Research Alliance (CARRA) Scientific Meeting : Toronto, Canada. 14-17 April 2016. Pediatric rheumatology online journal. 2016 Academic Article GET IT
-
The Role of Complement Inhibition in Thrombotic Angiopathies and Antiphospholipid Syndrome.
Turkish journal of haematology : official journal of Turkish Society of Haematology.
2016
Information Resource
GET IT
Times cited: 39 -
The contribution of antiphospholipid antibodies to organ damage in systemic lupus erythematosus.
Lupus.
2016
Academic Article
GET IT
Times cited: 21 -
Recognition and management of antiphospholipid syndrome.
Current opinion in rheumatology.
2016
Information Resource
GET IT
Times cited: 18 - The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus. European journal of rheumatology. 2015 Review GET IT
-
Pregnancy-Related Challenges in Systemic Autoimmune Diseases.
Journal of infusion nursing : the official publication of the Infusion Nurses Society.
2015
Academic Article
GET IT
Times cited: 2 -
How I treat catastrophic thrombotic syndromes.
Blood.
2015
Information Resource
GET IT
Times cited: 32 -
Rapidly Progressive Cardiac Failure Due to Giant Cell Myocarditis: A Clinical Pathology Conference Held by the Division of Rheumatology at Hospital for Special Surgery.
HSS journal : the musculoskeletal journal of Hospital for Special Surgery.
2015
Academic Article
GET IT
Times cited: 2 -
Patients with overlap autoimmune disease differ from those with 'pure' disease.
Lupus science & medicine.
2015
Academic Article
GET IT
Times cited: 30 -
Short-term patient-centered nutrition counseling impacts weight and nutrient intake in patients with systemic lupus erythematosus.
Lupus.
2015
Academic Article
GET IT
Times cited: 22 -
The association between antiphospholipid antibodies and pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature.
Lupus.
2015
Information Resource
GET IT
Times cited: 38 -
The challenge of bleeding in antiphospholipid antibody-positive patients.
Current rheumatology reports.
2015
Information Resource
GET IT
Times cited: 23 -
Social capital: a novel platform for understanding social determinants of health in systemic lupus erythematosus.
Lupus.
2014
Academic Article
GET IT
Times cited: 1 -
Lepromatous leprosy mimicking systemic lupus erythematosus: a clinical pathology conference held by the division of rheumatology at hospital for special surgery.
HSS journal : the musculoskeletal journal of Hospital for Special Surgery.
2014
Academic Article
GET IT
Times cited: 13 -
Reply: To PMID 23861221.
Arthritis care & research.
2014
Letter
GET IT
Times cited: 1 -
Catastrophic antiphospholipid syndrome: how to diagnose a rare but highly fatal disease.
Therapeutic advances in musculoskeletal disease.
2013
Information Resource
GET IT
Times cited: 52 -
Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: an international and collaborative meta-analysis.
Autoimmunity reviews.
2013
Information Resource
GET IT
Times cited: 110 -
Top 10 clinical research developments in antiphospholipid syndrome.
Current rheumatology reports.
2013
Academic Article
GET IT
Times cited: 4 -
Cognitive dysfunction in antiphospholipid antibody (aPL)-negative systemic lupus erythematosus (SLE) versus aPL-positive non-SLE patients.
Clinical and experimental rheumatology.
2013
Academic Article
GET IT
Times cited: 23 -
Comment: discordant aPTT and anti-Xa values and outcomes in hospitalized patients treated with intravenous unfractionated heparin.
The Annals of pharmacotherapy.
2013
Article
GET IT
Times cited: 3 -
Systemic Lupus Erythematosus Associated with Rowell's Syndrome: A Clinical Pathology Conference Held by the Division of Rheumatology at Hospital for Special Surgery.
HSS journal : the musculoskeletal journal of Hospital for Special Surgery.
2013
Academic Article
GET IT
Times cited: 5 -
A prospective open-label pilot study of fluvastatin on proinflammatory and prothrombotic biomarkers in antiphospholipid antibody positive patients.
Annals of the rheumatic diseases.
2013
Academic Article
GET IT
Times cited: 103 -
Could statins be a new therapeutic option for antiphospholipid syndrome patients?.
Expert review of hematology.
2013
Editorial Article
GET IT
Times cited: 4 -
A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome.
Arthritis and rheumatism.
2013
Academic Article
GET IT
Times cited: 167 -
Site differences in mild cognitive dysfunction (MCD) among patients with systemic lupus erythematosus (SLE).
Lupus.
2013
Academic Article
GET IT
Times cited: 10 -
The optimal tool for assessment of organ damage in antiphospholipid syndrome.
The Journal of rheumatology.
2013
Article
GET IT
Times cited: 11 -
Clinical causes and treatment of the thrombotic storm.
Expert review of hematology.
2012
Information Resource
GET IT
Times cited: 15 -
Churg-strauss syndrome with eosinophilic myocarditis: a clinical pathology conference held by the division of rheumatology at hospital for special surgery.
HSS journal : the musculoskeletal journal of Hospital for Special Surgery.
2012
Academic Article
GET IT
Times cited: 5 - Research studies and their implications for social work practice in a multidisciplinary center for lupus care. Social work in health care. 2012 Academic Article GET IT
-
Clinical assessment and management of cytopenias in lupus patients.
Current rheumatology reports.
2011
Information Resource
GET IT
Times cited: 20 -
Thrombotic storm revisited: preliminary diagnostic criteria suggested by the thrombotic storm study group.
The American journal of medicine.
2011
Information Resource
GET IT
Times cited: 27 -
Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions.
Lupus.
2011
Academic Article
GET IT
Times cited: 67 -
Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations.
Lupus.
2011
Academic Article
GET IT
Times cited: 55 - Cyclophosphamide responsive interstitial lung disease in "overlap syndrome": a clinical pathology conference held by the division of rheumatology at the hospital for special surgery. HSS journal : the musculoskeletal journal of Hospital for Special Surgery. 2010 Academic Article GET IT
-
Catastrophic antiphospholipid syndrome: updated diagnostic algorithms.
Autoimmunity reviews.
2010
Information Resource
GET IT
Times cited: 103 -
Large-vessel granulomatous vasculitis in Crohn's disease: a clinical pathology conference held by the division of rheumatology at hospital for special surgery.
HSS journal : the musculoskeletal journal of Hospital for Special Surgery.
2010
Academic Article
GET IT
Times cited: 2 -
Antiphospholipid syndrome treatment beyond anticoagulation: are we there yet?.
Lupus.
2010
Information Resource
GET IT
Times cited: 50 - Risk quantification in antiphospholipid syndrome. Women's health (London, England). 2010 Comment GET IT
-
Moderate versus high-titer persistently anticardiolipin antibody positive patients: are they clinically different and does high-titer anti-beta 2-glycoprotein-I antibody positivity offer additional predictive information?.
Lupus.
2009
Academic Article
GET IT
Times cited: 24 - Hepatitis C- and human immunodeficiency virus-induced hypersensitivity vasculitis: a clinical pathology conference held by the division of rheumatology at hospital for special surgery. HSS journal : the musculoskeletal journal of Hospital for Special Surgery. 2009 Academic Article GET IT
-
Overlap between systemic lupus erythematosus and Kikuchi Fujimoto disease: a clinical pathology conference held by the Department of Rheumatology at Hospital for Special Surgery.
HSS journal : the musculoskeletal journal of Hospital for Special Surgery.
2009
Conference Paper
GET IT
Times cited: 16 -
Catastrophic antiphospholipid syndrome: treatment, prognosis, and the risk of relapse.
Clinical reviews in allergy & immunology.
2009
Information Resource
GET IT
Times cited: 37 -
New approaches for managing antiphospholipid syndrome.
Nature clinical practice. Rheumatology.
2009
Information Resource
GET IT
Times cited: 53 -
Management of the controversial aspects of the antiphospholipid syndrome pregnancies: a guide for clinicians and researchers.
Rheumatology (Oxford, England).
2008
Academic Article
GET IT
Times cited: 57 -
Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment.
Seminars in thrombosis and hemostasis.
2008
Information Resource
GET IT
Times cited: 28 -
Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
Annals of the rheumatic diseases.
2007
Academic Article
GET IT
Times cited: 33 -
Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals.
Arthritis and rheumatism.
2007
Academic Article
GET IT
Times cited: 286 -
Assessment of the 2006 revised antiphospholipid syndrome classification criteria.
Annals of the rheumatic diseases.
2007
Academic Article
GET IT
Times cited: 84 -
The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus.
The Journal of rheumatology.
2007
Academic Article
GET IT
Times cited: 84 -
Lupus and thrombosis.
The Journal of rheumatology.
2006
Editorial Article
GET IT
Times cited: 25 -
Cardiac manifestations in the antiphospholipid syndrome.
Rheumatic diseases clinics of North America.
2006
Information Resource
GET IT
Times cited: 35 -
Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients.
Arthritis and rheumatism.
2006
Academic Article
GET IT
Times cited: 213 -
Therapeutic and prognostic considerations in catastrophic antiphospholipid syndrome.
Autoimmunity reviews.
2006
Information Resource
GET IT
Times cited: 49 -
Antiphospholipid syndrome.
Current opinion in rheumatology.
2006
Information Resource
GET IT
Times cited: 34 -
Catastrophic antiphospholipid syndrome.
Journal of intensive care medicine.
2006
Information Resource
GET IT
Times cited: 60 -
New treatments for antiphospholipid syndrome.
Rheumatic diseases clinics of North America.
2006
Information Resource
GET IT
Times cited: 38 -
Methotrexate use in rheumatoid arthritis is associated with few clinically significant liver function test abnormalities.
Clinical and experimental rheumatology.
2005
Academic Article
GET IT
Times cited: 25 -
Real world experience with antiphospholipid antibody tests: how stable are results over time?.
Annals of the rheumatic diseases.
2005
Academic Article
GET IT
Times cited: 66 -
Warfarin in antiphospholipid syndrome--time to explore new horizons.
The Journal of rheumatology.
2005
Editorial Article
GET IT
Times cited: 12 -
Cardiac involvement in the antiphospholipid syndrome.
Lupus.
2005
Information Resource
GET IT
Times cited: 75 -
Challenges in bringing the bench to bedside in drug development for SLE.
Nature reviews. Drug discovery.
2004
Information Resource
GET IT
Times cited: 36 -
What is antiphospholipid syndrome?.
Current rheumatology reports.
2004
Information Resource
GET IT
Times cited: 32 -
Intravenous immunoglobulin and antiphospholipid syndrome: comment on the article by Erkan et al.
Arthritis and rheumatism.
2004
Article
GET IT
Times cited: 3 -
Behçet's disease: does lack of knowledge result in under-diagnosis?.
Clinical and experimental rheumatology.
2004
Letter
GET IT
Times cited: 3 -
Do etanercept-naive patients with rheumatoid arthritis respond better to infliximab than patients for whom etanercept has failed?.
Annals of the rheumatic diseases.
2004
Article
GET IT
Times cited: 26 -
Is Hughes-Stovin syndrome Behçet's disease?
2004
GET IT
Times cited: 55 -
Catastrophic antiphospholipid syndrome: where do we stand?.
Arthritis and rheumatism.
2003
Information Resource
GET IT
Times cited: 93 -
Eligibility of rheumatoid arthritis patients seen in clinical practice for rheumatoid arthritis clinical trials: comment on the article by Sokka and Pincus.
Arthritis and rheumatism.
2003
Letter
GET IT
Times cited: 5 - Analysis of risk factors and comorbid diseases in the development of thrombosis in patients with anticardiolipin antibodies: comment on the article by Sairam et al. Clinical rheumatology. 2003 Article GET IT
-
Monitoring by rheumatologists for methotrexate-, etanercept-, infliximab-, and anakinra-associated adverse events.
Arthritis and rheumatism.
2003
Academic Article
GET IT
Times cited: 32 -
New insights into pregnancy-related complications in systemic lupus erythematosus.
Current rheumatology reports.
2003
Information Resource
GET IT
Times cited: 13 -
Treatment of the antiphospholipid syndrome.
The New England journal of medicine.
2003
Editorial Article
GET IT
Times cited: 70 - Cutaneous clues to connective tissue diseases: Systemic lupus erythematosus. Consultant. 2003 Article
-
Long term outcome of catastrophic antiphospholipid syndrome survivors.
Annals of the rheumatic diseases.
2003
Academic Article
GET IT
Times cited: 138 - The impact of pharmacoeconomics on the treatment of rheumatoid arthritis: A 3-year longitudinal study. Drug Benefit Trends. 2003 Article
-
Cardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report.
Lupus.
2003
Conference Paper
GET IT
Times cited: 105 -
Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines.
Lupus.
2003
Conference Paper
GET IT
Times cited: 598 - Cutaneous clues to rheumatic diseases: Psoriatic arthritis. Consultant. 2003 Article
-
Pregnancy outcomes following total hip arthroplasty: a preliminary study and review of the literature.
Orthopedics.
2003
Academic Article
GET IT
Times cited: 11 -
The relation between antiphospholipid syndrome-related pregnancy morbidity and non-gravid vascular thrombosis: a review of the literature and management strategies.
Current rheumatology reports.
2002
Information Resource
GET IT
Times cited: 18 -
A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome.
Rheumatology (Oxford, England).
2002
Academic Article
GET IT
Times cited: 253 -
Monitoring methotrexate hepatic toxicity in rheumatoid arthritis: is it time to update the guidelines?.
The Journal of rheumatology.
2002
Editorial Article
GET IT
Times cited: 25 -
Decreased flares of rheumatoid arthritis during the first year of etanercept treatment: further evidence of clinical effectiveness in the "real world".
Annals of the rheumatic diseases.
2002
Academic Article
GET IT
Times cited: 14 -
Physician treatment preferences in rheumatoid arthritis of differing disease severity and activity: the impact of cost on first-line therapy.
Arthritis and rheumatism.
2002
Academic Article
GET IT
Times cited: 28 -
Dual antibody reactivity to beta2-glycoprotein I and protein S: increased association with thrombotic events in the antiphospholipid syndrome.
Lupus.
2002
Academic Article
GET IT
Times cited: 40 -
Etanercept in the treatment of severe, resistant psoriatic arthritis: continued efficacy and changing patterns of use after two years.
Clinical and experimental rheumatology.
2002
Article
GET IT
Times cited: 16 -
Reporting consistency in systemic lupus erythematosus patients: how reliable are patient histories?.
Lupus.
2002
Academic Article
GET IT
Times cited: 2 - The impact of pharmacoeconomics on the treatment of rheumatoid arthritis. Drug Benefit Trends. 2002 Article
-
High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin.
Arthritis and rheumatism.
2001
Academic Article
GET IT
Times cited: 164 -
Morning stiffness: how common is it and does it correlate with physician and patient global assessment of disease activity?.
The Journal of rheumatology.
2001
Article
GET IT
Times cited: 19 -
Lupus anticoagulant--hypoprothrombinemia syndrome and pregnancy.
Lupus.
2001
Article
GET IT
Times cited: 4 -
Primary antiphospholipid syndrome: functional outcome after 10 years.
The Journal of rheumatology.
2000
Academic Article
GET IT
Times cited: 66 -
A preliminary study of etanercept in the treatment of severe, resistant psoriatic arthritis.
Clinical and experimental rheumatology.
2000
Academic Article
GET IT
Times cited: 48 - Severe guillain-barre-like peripheral neuropathy in a patient with systemic lupus erythematosus: recovery after two separate accidental burn injuries. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases. 2000 Academic Article GET IT
-
A case of VATER association mimicking spondylarthropathy.
Clinical and experimental rheumatology.
2000
Article
GET IT
Times cited: 1